(Q42908570)

10 November 2017

title

Multi-walled carbon nanotubes conjugated to tumor protein enhance the uptake of tumor antigens by human dendritic cells in vitro (English)

1 reference

10 November 2017

1 reference

1 reference

Zhao Sun

1

1 reference

10 November 2017

Wei Wang

2

1 reference

10 November 2017

Jie Meng

3

1 reference

10 November 2017

Shuchang Chen

4

1 reference

10 November 2017

Haiyan Xu

5

1 reference

10 November 2017

Xian-Da Yang

6

1 reference

10 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20838419

12 July 2024

publication date

14 September 2010

1 reference

full work available at URL

10 November 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

https://www.nature.com/articles/cr2010133.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20838419

http://www.nature.com/articles/cr2010133.pdf

12 July 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/CR.2010.133

http://www.nature.com/articles/cr2010133

12 July 2024

1 reference

https://api.crossref.org/works/10.1038/CR.2010.133

12 July 2024

1 reference

10 November 2017

volume

20

1 reference

10 November 2017

issue

10

1 reference

10 November 2017

page(s)

1170-1173

1 reference

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

10 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.133

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.133

Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.133

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.133

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.133

Dendritic cells in vaccination therapies of malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.133

Biomedical applications of functionalised carbon nanotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.133

Carbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.133

A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.133

A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.133

21 January 2018

Identifiers

DOI

10.1038/CR.2010.133

1 reference

Dimensions Publication ID

10 November 2017

1047793715

0 references

1 reference